a simultaneous view of CT scans, MRIs, and other test results. Called the Radiology Theatre, the system is the first telemedicine application for IBM’s proprietary Web application development platform, Blue Spruce.
—The FDA approved two new tests from Bedford, MA-based Hologic (NASDAQ:[[ticker:HOLX]]), a maker of diagnostics and other devices for women’s healthcare. The tests detect various strains of human papillomavirus (HPV), a major cause of cervical cancer.
—Lexington, MA-based Pulmatrix reportedly raised $3 million from unnamed investors. Previous backers of the six-year-old firm, which is developing aerosol drugs for treating respiratory diseases and preventing their spread, include 5AM Ventures and Polaris Venture Partners.
—Ryan profiled scientist/serial entrepreneur (and Xconomist) Carmichael Roberts, whose expertise in chemistry and materials science is helping to broaden the focus of North Bridge Venture Partners, which previously emphasized IT-based investments. Roberts also dropped a few hints about his new startup in Waltham, MA, called MC10 (for now), which is out to develop “stretchable silicon” for use in bendable medical implants and electronics.
—Newton, MA-based NKT Therapeutics raised $8 million in a Series A financing led by SV Life Sciences and MedImmune Ventures. NKT is using technology from Boston’s Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, and Massachusetts General Hospital to develop treatments for asthma, cancer, autoimmune diseases, and other ailments.
—Still River Systems of Littleton, MA, raised $33 million to help speed the development of its smaller, more affordable version of a proton radiotherapy system for cancer treatment. Venrock Associates and previous investor Caxton Health and Life Sciences led the deal, and CHL Medical Partners participated as well.
